K212160

Substantially Equivalent

SimpleSENSE Platform

Applicant: Nanowear, Inc.
Product code: DXH
Advisory panel: Cardiovascular
Date received: 2021-07-12
Decision date: 2021-09-22
Decision: Substantially Equivalent
Clearance type: Special
Location: Brooklyn, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.